| Attribute |
Value |
| 52 Week Change |
0.35555553 |
| Address1 |
Building 23 |
| Address2 |
Suite 105 221 Crescent Street |
| All Time High |
1,134.525 |
| All Time Low |
6.565 |
| Ask |
17.01 |
| Ask Size |
2 |
| Audit Risk |
6 |
| Average Analyst Rating |
1.0 - Strong Buy |
| Average Daily Volume10 Day |
1,025,230 |
| Average Daily Volume3 Month |
892,131 |
| Average Volume |
892,131 |
| Average Volume10Days |
1,025,230 |
| Bid |
9.67 |
| Bid Size |
2 |
| Board Risk |
7 |
| Book Value |
6.922 |
| City |
Waltham |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Compensation Risk |
10 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
13.42 |
| Current Ratio |
14.927 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,790,726,400 |
| Day High |
13.655 |
| Day Low |
12.8465 |
| Debt To Equity |
0.316 |
| Display Name |
Jade Biosciences |
| Dividend Date |
1,745,798,400 |
| Dividend Yield |
0.0 |
| Earnings Timestamp |
1,786,365,000 |
| Earnings Timestamp End |
1,794,486,600 |
| Earnings Timestamp Start |
1,794,486,600 |
| Ebitda |
-164,702,000 |
| Ebitda Margins |
0.0 |
| Enterprise To Ebitda |
-2.39 |
| Enterprise Value |
393,662,944 |
| Eps Current Year |
-2.93236 |
| Eps Forward |
-2.66261 |
| Eps Trailing Twelve Months |
-1.92 |
| Esg Populated |
0 |
| Exchange |
NCM |
| Exchange Data Delayed By |
15 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
18.6442 |
| Fifty Day Average Change |
-5.2241993 |
| Fifty Day Average Change Percent |
-0.28020507 |
| Fifty Two Week Change Percent |
35.555553 |
| Fifty Two Week High |
28.0 |
| Fifty Two Week High Change |
-14.58 |
| Fifty Two Week High Change Percent |
-0.5207143 |
| Fifty Two Week Low |
8.36 |
| Fifty Two Week Low Change |
5.0600004 |
| Fifty Two Week Low Change Percent |
0.60526323 |
| Fifty Two Week Range |
8.36 - 28.0 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,625,059,800,000 |
| Float Shares |
51,973,057 |
| Forward Eps |
-2.66261 |
| Forward P E |
-5.0401673 |
| Full Exchange Name |
NasdaqCM |
| Full Time Employees |
55 |
| Fullday Change |
0.0 |
| Fullday Change Percent |
0.0 |
| Fullday Price |
13.42 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,790,812,800 |
| Gross Margins |
0.0 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.00794 |
| Held Percent Institutions |
1.1610501 |
| Implied Shares Outstanding |
63,597,387 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Dividend Date |
1,745,884,800 |
| Last Dividend Value |
2.4 |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,745,884,800 |
| Last Split Factor |
1:35 |
| Long Business Summary |
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts. |
| Long Name |
Jade Biosciences, Inc. |
| Market |
us_market |
| Market Cap |
853,476,928 |
| Market State |
REGULAR |
| Max Age |
86,400 |
| Message Board Id |
finmb_1889513328 |
| Most Recent Quarter |
1,782,777,600 |
| Net Income To Common |
-124,442,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
934,245,615 |
| Number Of Analyst Opinions |
8 |
| Open |
13.22 |
| Operating Cashflow |
-123,510,000 |
| Operating Margins |
0.0 |
| Overall Risk |
9 |
| Phone |
781 312 3013 |
| Previous Close |
13.42 |
| Price Eps Current Year |
-4.5765185 |
| Price Hint |
2 |
| Price To Book |
1.9387461 |
| Profit Margins |
0.0 |
| Quick Ratio |
14.609 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
strong_buy |
| Recommendation Mean |
1.0 |
| Region |
US |
| Regular Market Change |
0.0 |
| Regular Market Change Percent |
0.0 |
| Regular Market Day High |
13.655 |
| Regular Market Day Low |
12.8465 |
| Regular Market Day Range |
12.8465 - 13.655 |
| Regular Market Open |
13.22 |
| Regular Market Previous Close |
13.42 |
| Regular Market Price |
13.42 |
| Regular Market Time |
1,792,007,226 |
| Regular Market Volume |
869,601 |
| Sand P52 Week Change |
0.17004645 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Share Holder Rights Risk |
8 |
| Shares Outstanding |
63,597,387 |
| Shares Percent Shares Out |
0.1906 |
| Shares Short |
12,119,108 |
| Shares Short Previous Month Date |
1,788,134,400 |
| Shares Short Prior Month |
9,994,410 |
| Short Name |
Jade Biosciences, Inc. |
| Short Percent Of Float |
0.2332 |
| Short Ratio |
12.01 |
| Source Interval |
15 |
| State |
MA |
| Symbol |
JBIO |
| Target High Price |
77.0 |
| Target Low Price |
40.0 |
| Target Mean Price |
50.125 |
| Target Median Price |
47.0 |
| Total Cash |
461,204,992 |
| Total Cash Per Share |
7.252 |
| Total Debt |
1,389,000 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-1.92 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
18.243176 |
| Two Hundred Day Average Change |
-4.8231754 |
| Two Hundred Day Average Change Percent |
-0.26438245 |
| Type Disp |
Equity |
| Volume |
869,601 |
| Website |
https://jadebiosciences.com |
| Zip |
2,453 |